Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
December 2nd, 2014
17.3K views
We describe a technique for measuring aortic stiffness from its pressure-diameter relationship in vivo in mice. Aortic diameter is recorded by ultrasound and aortic pressure is measured invasively with a solid-state pressure catheter. Blood pressure is changed incrementally and the resulting diameter is measured.
Overview
This article describes a technique for measuring aortic stiffness in vivo in mice by assessing the pressure-diameter relationship of the aorta. The method involves using ultrasound to record aortic diameter and an invasive solid-state pressure catheter to measure aortic pressure.
Key Study Components
Area of Science
- Cardiovascular physiology
- In vivo imaging techniques
- Aortic compliance measurement
Background
- Aortic stiffness is an important indicator of cardiovascular health.
- Traditional methods like pulse wave velocity do not measure local aortic stiffness.
- This technique allows for direct measurement of aortic diameter changes in response to pressure variations.
- Vasoactive drugs are used to manipulate blood pressure during measurements.
Purpose of Study
- To develop a reliable method for measuring aortic stiffness in live mice.
- To assess the pressure dependency of aortic stiffness through direct measurement.
- To improve understanding of cardiovascular dynamics in experimental models.
Methods Used
- Intravenous administration of vasoactive drugs via a catheter.
- Invasive blood pressure measurement using a pressure catheter.
- Ultrasound imaging to visualize and track aortic diameter.
- Incremental changes in blood pressure to record corresponding aortic diameter changes.
Main Results
- Successful measurement of aortic diameter changes in response to varying pressures.
- Data collected can be used to calculate aortic compliance.
- Demonstrated the effectiveness of the technique in measuring local aortic stiffness.
- Provided insights into the pressure dependency of aortic stiffness.
Conclusions
- This technique offers a novel approach to assess aortic stiffness in vivo.
- It enhances the understanding of cardiovascular mechanics in experimental settings.
- The method could be beneficial for future research in cardiovascular diseases.
Frequently Asked Questions
What is the significance of measuring aortic stiffness?
Aortic stiffness is a critical indicator of cardiovascular health and can help assess the risk of heart disease.
How does this technique differ from traditional methods?
Unlike traditional methods, this technique measures local aortic stiffness directly rather than relying on indirect assessments.
What role do vasoactive drugs play in this study?
Vasoactive drugs are used to manipulate blood pressure, allowing researchers to observe changes in aortic diameter in response to pressure variations.
Is this method applicable to other animal models?
While this study focuses on mice, the technique could potentially be adapted for use in other animal models.
What are the potential implications of this research?
This research could lead to better understanding and treatment of cardiovascular diseases by providing insights into aortic mechanics.
Executive Industry Relevance
Quantitative measurement of ascending aortic stiffness in vivo using ultrasound and invasive pressure monitoring enables precise evaluation of vascular compliance in preclinical models. This approach supports mechanistic de-risking and target validation for cardiovascular drug discovery by providing physiologically relevant data on vessel biomechanics. The method enhances predictive confidence at the early discovery and translational inflection points for cardiovascular portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of vascular stiffness mechanisms in disease-relevant mouse models.
- Supports functional target validation by quantifying pressure-diameter relationships under controlled hemodynamic conditions.
- Facilitates biological de-risking by distinguishing local aortic stiffness from systemic vascular changes.
Screening & Assay Development
- Provides validated, quantitative readouts of aortic compliance for downstream compound evaluation.
- Standardizes measurement of biomechanical endpoints, improving reproducibility across studies.
- Establishes a platform for scalable assessment of vascular-targeted interventions in vivo.
Translational & Preclinical Research
- Aligns preclinical vascular stiffness measurements with translational biomarker strategies for cardiovascular disease.
- Enables continuity from mechanistic discovery to preclinical validation of therapeutic hypotheses.
- Supports risk-adjusted advancement decisions by providing physiologically relevant endpoints.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling hypothesis testing, target validation, and quantitative assessment of vascular function in live animal models.
- Discovery Biology: Supports mechanistic hypothesis testing and pathway clarification for vascular stiffness.
- Screening: Delivers reproducible, quantitative compliance data for compound triage.
- Analytics: Generates pressure-diameter curves and compliance indices for robust statistical comparison.
- Translational Research: Bridges discovery findings to preclinical biomarker development in cardiovascular research.
- Enterprise Reuse: Provides a reusable platform for evaluating diverse vascular-targeted modalities.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of in vivo vascular measurements.
- Strategic Value: Improves go/no-go decision-making and capital efficiency in cardiovascular portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of vascular-targeted assets.
Implementation Considerations
- Requires expertise in small animal surgery, ultrasound imaging, and invasive pressure monitoring.
- Demands access to high-resolution ultrasound and solid-state pressure catheter systems.
- Necessitates cross-team standardization of measurement protocols and data analysis.
- Adaptation may be needed for different mouse strains or vascular regions.
- Measurement error from aortic motion must be mitigated by probe adjustment and increased sample size.
Biopharma FAQs
Why does null hypothesis testing of pressure-diameter data matter for target validation?
Null hypothesis testing of pressure-diameter relationships enables objective assessment of whether interventions significantly alter aortic stiffness, supporting robust target validation in cardiovascular discovery workflows.
How does independent variable isolation via vasoactive drug infusion fit the discovery pipeline?
Isolating blood pressure changes through controlled vasoactive drug infusion allows precise attribution of aortic diameter responses to specific hemodynamic manipulations, strengthening mechanistic insights in early discovery.
What do quantitative dependent variable measurements of aortic compliance enable?
Quantitative compliance measurements provide reproducible, physiologically relevant endpoints for comparing interventions, facilitating data-driven compound triage and portfolio decision-making.
Why are replication requirements for pressure-diameter measurements critical for cross-functional collaboration?
Replication of pressure-diameter measurements ensures data reliability and comparability across teams, supporting collaborative validation and reducing experimental variability in multi-site studies.
What statistical analysis capabilities are required before implementing pressure-diameter curve assessments?
Robust statistical analysis of pressure-diameter and compliance data is essential to detect meaningful differences, establish reproducibility, and inform advancement decisions in cardiovascular R&D pipelines.
